IT1196190B - Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno - Google Patents

Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno

Info

Publication number
IT1196190B
IT1196190B IT21874/84A IT2187484A IT1196190B IT 1196190 B IT1196190 B IT 1196190B IT 21874/84 A IT21874/84 A IT 21874/84A IT 2187484 A IT2187484 A IT 2187484A IT 1196190 B IT1196190 B IT 1196190B
Authority
IT
Italy
Prior art keywords
pharmaceutical form
oral solid
solid pharmaceutical
ulcerogenous
drugs
Prior art date
Application number
IT21874/84A
Other languages
English (en)
Other versions
IT8421874A1 (it
IT8421874A0 (it
Inventor
Paolo Colombo
Ubaldo Conte
Giorgio Zagnoli
Original Assignee
Lisapharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lisapharma Spa filed Critical Lisapharma Spa
Priority to IT21874/84A priority Critical patent/IT1196190B/it
Publication of IT8421874A0 publication Critical patent/IT8421874A0/it
Priority to DE8585108146T priority patent/DE3581006D1/de
Priority to EP85108146A priority patent/EP0167958B1/en
Priority to AT85108146T priority patent/ATE59551T1/de
Priority to ES545067A priority patent/ES545067A0/es
Publication of IT8421874A1 publication Critical patent/IT8421874A1/it
Application granted granted Critical
Publication of IT1196190B publication Critical patent/IT1196190B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT21874/84A 1984-07-12 1984-07-12 Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno IT1196190B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT21874/84A IT1196190B (it) 1984-07-12 1984-07-12 Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
DE8585108146T DE3581006D1 (de) 1984-07-12 1985-07-01 Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
EP85108146A EP0167958B1 (en) 1984-07-12 1985-07-01 Oral solid pharmaceutical form with sequential action for the administering of drugs with ulcerogenic side effect
AT85108146T ATE59551T1 (de) 1984-07-12 1985-07-01 Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
ES545067A ES545067A0 (es) 1984-07-12 1985-07-11 Perfeccionamientos en formas farmaceuticas solidas para uso oral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21874/84A IT1196190B (it) 1984-07-12 1984-07-12 Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno

Publications (3)

Publication Number Publication Date
IT8421874A0 IT8421874A0 (it) 1984-07-12
IT8421874A1 IT8421874A1 (it) 1986-01-12
IT1196190B true IT1196190B (it) 1988-11-10

Family

ID=11188069

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21874/84A IT1196190B (it) 1984-07-12 1984-07-12 Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno

Country Status (5)

Country Link
EP (1) EP0167958B1 (it)
AT (1) ATE59551T1 (it)
DE (1) DE3581006D1 (it)
ES (1) ES545067A0 (it)
IT (1) IT1196190B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1301969B1 (it) * 1998-07-30 2000-07-20 Lisapharma Spa Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3715M (fr) * 1964-06-11 1965-11-29 Lucien Nouvel Antithermiques et antirhumatismaux améliorés.
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
IT1212778B (it) * 1983-10-07 1989-11-30 Lisapharma Spa Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.

Also Published As

Publication number Publication date
ATE59551T1 (de) 1991-01-15
ES8603262A1 (es) 1986-01-01
EP0167958A3 (en) 1987-06-03
IT8421874A1 (it) 1986-01-12
IT8421874A0 (it) 1984-07-12
DE3581006D1 (de) 1991-02-07
ES545067A0 (es) 1986-01-01
EP0167958A2 (en) 1986-01-15
EP0167958B1 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
GB1509979A (en) Pharmaceutical compositions containing aspirin or indomethacin
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
NO164092C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer.
FI883785A7 (fi) Kapseli lääkeaineen farmaseuttisesti vaikuttavaa inhalointiainetta varten.
BE896205A (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
ES520994A0 (es) Un metodo para la preparacion de una forma posologica unitaria solida, terapeuticamente activa, con pauta de liberacion regular y prolongada al ser administrada.
FI863074A7 (fi) Farmaseuttisesti aktiivisten aineiden rakeinen, hidasluovutteinen muoto.
SE9702533D0 (sv) New oral formulation
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
ATE71837T1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
FR2273515A1 (fr) Procede de fabrication d'un corps monolithique pour la liberation continue d'agents actifs, notamment de medicaments
ES2053768T3 (es) Tabletas masticables.
ATE66371T1 (de) Arzneimittelzubereitung mit verzoegerter freisetzung.
NO167660C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylmetylazoler og salter derav.
DE69425589D1 (de) Kombiniertes antipyretisches und analgetisches arzneimittel
IT1196190B (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DK374584D0 (da) Analgetikum
GR3004113T3 (it)
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 416

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 416, 19921214; LABORATORIO ITALIANO BIOCHIMICO FAR MACEUTICO LISAPHARMA SPA

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730